ALPEK. de Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
ALPEK. de wird ein jährliches Gewinn- und Umsatzwachstum von 106.2% bzw. 5.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 112.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 10.7% betragen.
Wichtige Informationen
106.2%
Wachstumsrate der Gewinne
112.8%
EPS-Wachstumsrate
Chemicals Gewinnwachstum | 47.8% |
Wachstumsrate der Einnahmen | 5.6% |
Zukünftige Eigenkapitalrendite | 10.7% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 21 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
ALPEK, S.A.B. de C.V. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 27Earnings Miss: ALPEK, S.A.B. de C.V. Missed EPS By 51% And Analysts Are Revising Their Forecasts
Apr 25Recent updates
Why We're Not Concerned About ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) Share Price
Oct 11Returns On Capital Signal Difficult Times Ahead For ALPEK. de (BMV:ALPEKA)
Sep 12Should You Investigate ALPEK, S.A.B. de C.V. (BMV:ALPEKA) At Mex$11.86?
Aug 21ALPEK, S.A.B. de C.V. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 27A Look At The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)
Jun 21Some Investors May Be Worried About ALPEK. de's (BMV:ALPEKA) Returns On Capital
Jun 06Earnings Miss: ALPEK, S.A.B. de C.V. Missed EPS By 51% And Analysts Are Revising Their Forecasts
Apr 25What ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) P/S Is Not Telling You
Apr 13At Mex$12.61, Is ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Worth Looking At Closely?
Mar 26ALPEK. de (BMV:ALPEKA) Has A Somewhat Strained Balance Sheet
Mar 08A Look At The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)
Jan 22Investor Optimism Abounds ALPEK, S.A.B. de C.V. (BMV:ALPEKA) But Growth Is Lacking
Jan 04Is There Now An Opportunity In ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?
Dec 14ALPEK. de (BMV:ALPEKA) Use Of Debt Could Be Considered Risky
Nov 24Is Now The Time To Look At Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?
Sep 02ALPEK. de (BMV:ALPEKA) Has A Somewhat Strained Balance Sheet
Jul 16ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) Intrinsic Value Is Potentially 91% Above Its Share Price
Jun 27The ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Analysts Have Been Trimming Their Sales Forecasts
Apr 30When Should You Buy ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?
Apr 20An Intrinsic Calculation For ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Suggests It's 34% Undervalued
Mar 28These Analysts Think ALPEK, S.A.B. de C.V.'s (BMV:ALPEKA) Sales Are Under Threat
Feb 25Is ALPEK. de (BMV:ALPEKA) A Risky Investment?
Feb 23Is It Too Late To Consider Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA)?
Jan 07Estimating The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)
Dec 22At Mex$26.92, Is ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Worth Looking At Closely?
Sep 24We Think ALPEK. de (BMV:ALPEKA) Can Stay On Top Of Its Debt
Aug 30Should You Think About Buying ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Now?
Jun 18Analysts Just Made A Neat Upgrade To Their ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Forecasts
May 28These 4 Measures Indicate That ALPEK. de (BMV:ALPEKA) Is Using Debt Reasonably Well
May 05Growth Investors: Industry Analysts Just Upgraded Their ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Revenue Forecasts By 11%
Feb 21Is ALPEK. de (BMV:ALPEKA) A Risky Investment?
Feb 01An Intrinsic Calculation For ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Suggests It's 23% Undervalued
Jan 10Is ALPEK, S.A.B. de C.V. (BMV:ALPEKA) Potentially Undervalued?
Dec 24ALPEK. de (BMV:ALPEKA) Seems To Use Debt Quite Sensibly
Oct 26Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 153,867 | 4,101 | 2,945 | 10,773 | 7 |
12/31/2025 | 146,404 | 2,973 | 3,661 | 8,075 | 11 |
12/31/2024 | 143,221 | 1,932 | 4,847 | 6,328 | 10 |
9/30/2024 | 132,434 | -10,103 | 6,209 | 8,372 | N/A |
6/30/2024 | 128,647 | -11,026 | 8,388 | 10,717 | N/A |
3/31/2024 | 131,934 | -10,686 | 10,852 | 13,447 | N/A |
12/31/2023 | 138,159 | -10,914 | 12,483 | 15,024 | N/A |
9/30/2023 | 156,683 | 767 | 15,202 | 17,496 | N/A |
6/30/2023 | 183,065 | 3,453 | 11,982 | 14,816 | N/A |
3/31/2023 | 203,133 | 8,955 | 9,704 | 12,462 | N/A |
12/31/2022 | 212,435 | 13,744 | 12,131 | 15,210 | N/A |
9/30/2022 | 208,689 | 13,602 | 12,683 | 15,800 | N/A |
6/30/2022 | 190,591 | 13,576 | 11,295 | 13,880 | N/A |
3/31/2022 | 171,271 | 10,001 | 10,672 | 15,314 | N/A |
12/31/2021 | 156,224 | 7,756 | 8,794 | 13,230 | N/A |
9/30/2021 | 140,268 | 9,175 | 5,278 | 9,901 | N/A |
6/30/2021 | 127,927 | 8,392 | 9,874 | 14,529 | N/A |
3/31/2021 | 118,297 | 6,028 | 8,280 | 10,941 | N/A |
12/31/2020 | 113,989 | 3,123 | 9,346 | 11,934 | N/A |
9/30/2020 | 112,413 | 5,151 | 8,180 | 10,785 | N/A |
6/30/2020 | 112,662 | 4,691 | 6,026 | 8,838 | N/A |
3/31/2020 | 116,640 | 5,635 | 8,295 | 11,168 | N/A |
12/31/2019 | 119,685 | 6,605 | 6,843 | 10,001 | N/A |
9/30/2019 | 127,354 | 10,373 | 7,623 | 10,296 | N/A |
6/30/2019 | 134,627 | 10,913 | 6,682 | 9,149 | N/A |
3/31/2019 | 137,345 | 12,601 | 5,915 | 8,231 | N/A |
12/31/2018 | 134,523 | 13,633 | 6,256 | 8,261 | N/A |
9/30/2018 | 124,731 | 5,240 | 6,239 | 8,372 | N/A |
6/30/2018 | 111,272 | -3,406 | N/A | 6,457 | N/A |
3/31/2018 | 101,404 | -5,707 | N/A | 7,484 | N/A |
12/31/2017 | 98,998 | -5,487 | N/A | 7,225 | N/A |
9/30/2017 | 97,416 | -4,366 | N/A | 6,004 | N/A |
6/30/2017 | 97,173 | 3,697 | N/A | 8,961 | N/A |
3/31/2017 | 95,240 | 4,112 | N/A | 7,739 | N/A |
12/31/2016 | 90,192 | 3,625 | N/A | 6,019 | N/A |
9/30/2016 | 87,174 | 3,558 | N/A | 6,724 | N/A |
6/30/2016 | 86,103 | 3,248 | N/A | 6,949 | N/A |
3/31/2016 | 85,161 | 3,654 | N/A | 6,940 | N/A |
12/31/2015 | 83,590 | 2,748 | N/A | 8,178 | N/A |
9/30/2015 | 85,981 | 1,844 | N/A | 9,631 | N/A |
6/30/2015 | 85,331 | 1,615 | N/A | 7,471 | N/A |
3/31/2015 | 84,935 | 860 | N/A | 5,379 | N/A |
12/31/2014 | 86,072 | 801 | N/A | 6,593 | N/A |
9/30/2014 | 84,225 | 1,105 | N/A | 4,950 | N/A |
6/30/2014 | 86,022 | 1,248 | N/A | 5,178 | N/A |
3/31/2014 | 87,636 | -198 | N/A | 7,051 | N/A |
12/31/2013 | 90,061 | 262 | N/A | 5,542 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ALPEK A wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (8.1%).
Ertrag vs. Markt: ALPEK A wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.
Hohe Wachstumserträge: ALPEK A wird voraussichtlich in den nächsten 3 Jahren rentabel werden.
Einnahmen vs. Markt: ALPEK ADie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt MX (7.2% pro Jahr).
Hohe Wachstumseinnahmen: ALPEK ADie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: ALPEK ADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (10.7%).